Literature DB >> 8621027

Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro.

J W Kolaczynski1, M R Nyce, R V Considine, G Boden, J J Nolan, R Henry, S R Mudaliar, J Olefsky, J F Caro.   

Abstract

This study was undertaken to investigate the changes in obesity (OB) gene expression and production of leptin in response to insulin in vitro and in vivo under euglycemic and hyperglycemic conditions in humans. Three protocols were used: 1) euglycemic clamp with insulin infusion rates at 40, 120, 300, and 1,200 mU / m / min carried out for up to 5 h performed in 16 normal lean individuals, 30 obese individuals, and 31 patients with NIDDM; 2) 64-to 72-h hyperglycemic (glucose 12.6 mmol/l) clamp performed on 5 lean individuals; 3) long-term (96-h) primary culture of isolated abdominal adipocytes in the presence and absence of 100 nmol/l insulin. Short-term hyperinsulinemia in the range of 80 to > 10,000 microU/ml had no effect on circulating levels of leptin. During the prolonged hyperglycemic clamp, a rise in leptin was observed during the last 24 h of the study (P < 0.001). In the presence of insulin in vitro, OB gene expression increased at 72 h (P < 0.01), followed by an increase in leptin released to the medium (P < 0.001). In summary, insulin does not stimulate leptin production acutely; however, a long-term effect of insulin on leptin production could be demonstrated both in vivo and in vitro. These data suggest that insulin regulates OB gene expression and leptin production indirectly, probably through its trophic effect on adipocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621027     DOI: 10.2337/diab.45.5.699

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  77 in total

Review 1.  Hormonal regulation of physiological cell turnover and apoptosis.

Authors:  R D Medh; E B Thompson
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

2.  Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects.

Authors:  G Boden; X Chen; J W Kolaczynski; M Polansky
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 3.  Plasma leptin and exercise: recent findings.

Authors:  Matthew W Hulver; Joseph A Houmard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 4.  Therapy of diabetes and dyslipidemia in acromegaly.

Authors:  G Tamburrano; C Durante; R Baldelli
Journal:  Pituitary       Date:  2002-01       Impact factor: 4.107

5.  Decreased serum leptin levels during prolonged high altitude exposure.

Authors:  Marco Zaccaria; Andrea Ermolao; Piero Bonvicini; Giuseppe Travain; Maurizio Varnier
Journal:  Eur J Appl Physiol       Date:  2004-04-09       Impact factor: 3.078

Review 6.  Pediatric endocrine disorders of energy balance.

Authors:  Robert H Lustig
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

7.  Is there an estrogenic component in the metabolic syndrome?

Authors:  S Starcke; G Vollmer
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

8.  Leptin levels in patients with type 1 diabetes receiving intensive insulin therapy compared with those in patients receiving conventional insulin therapy.

Authors:  S T Azar; P A Zalloua; M S Zantout; C H Shahine; I Salti
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

9.  Loss of protein kinase Cbeta function protects mice against diet-induced obesity and development of hepatic steatosis and insulin resistance.

Authors:  Wei Huang; Rishipal Bansode; Madhu Mehta; Kamal D Mehta
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

10.  Central insulin action regulates peripheral glucose and fat metabolism in mice.

Authors:  Linda Koch; F Thomas Wunderlich; Jost Seibler; A Christine Könner; Brigitte Hampel; Sigrid Irlenbusch; Georg Brabant; C Ronald Kahn; Frieder Schwenk; Jens C Brüning
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.